Oropharyngeal cancer is a type of head and neck cancer. It affects the cells in the middle part of your throat, or what’s called the oropharynx. Early signs are easy to miss. “We can't see that area ...
The management of human papillomavirus (HPV)-positive oropharyngeal cancer is shifting as oncologists balance high cure rates ...
The oropharyngeal cancer market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as PDS Biotechnology's Versamune HPV, Inovio ...
Dr Ranee Mehra emphasizes that de-escalating HPV-positive head and neck cancer care requires careful patient selection and ...
Oral Cancer Awareness Month is observed every April, and it highlights the urgent need for early detection. According to the ...
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...
A new study published today in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with ...
AI-based classification of laryngeal dysplasia and lymphocytic activity quantification from routine histology. AI-driven reflectance confocal microscopy for noninvasive diagnosis and accurate surgical ...
Older Americans with oropharyngeal and oral cancers face high medical costs but are missing out on needed dental care, according to a new study by Associate Professor Onur Baser and colleagues. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results